Delcor Asset Corporation et al v. Glenmark Pharmaceuticals Limited et al
Delcor Asset Corporation and Mylan Pharmaceuticals Inc. |
Glenmark Pharmaceuticals Limited, Glenmark Pharmaceuticals Inc., USA and Stiefel West Coast, LLC |
1:2017cv01653 |
November 15, 2017 |
US District Court for the District of Delaware |
Wilmington Office |
New Castle |
Richard G. Andrews |
Patent - Abbreviated New Drug Application |
35 U.S.C. ยง 271 |
None |
Available Case Documents
The following documents for this case are available for you to view or download:
Document Text |
---|
Filing 93 MEMORANDUM ORDER providing claim construction for multiple terms in U.S. Patent Nos. 7,141,237 and 7,374,747. Signed by Judge Richard G. Andrews on 10/31/2018. (nms) |
Filing 90 MEMORANDUM ORDER: The Partial Motion to Dismiss Glenmark's Third Counterclaim (D.I. 28 ) is GRANTED. Signed by Judge Richard G. Andrews on 9/21/2018. (nms) |
Use the links below to access additional information about this case on the US Court's PACER system. A subscription to PACER is required.
Access this case on the Delaware District Court's Electronic Court Filings (ECF) System
- Search for Party Aliases
- Associated Cases
- Attorneys
- Case File Location
- Case Summary
- Docket Report
- History/Documents
- Parties
- Related Transactions
- Check Status
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.